{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Grand Prairie",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74588",
      "recalling_firm": "Dream Body Weight Loss",
      "address_1": "2330 S Belt Line Rd",
      "address_2": "N/A",
      "postal_code": "75051-4151",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "United States",
      "recall_number": "D-0106-2017",
      "product_description": "Dream Body Extreme Gold 800 mg 30 capsules in a plastic screw on top bottle",
      "product_quantity": "Unknown",
      "reason_for_recall": "Marketed without an approved NDA/ANDA: Undeclared sibutramine.",
      "recall_initiation_date": "20160701",
      "center_classification_date": "20161019",
      "termination_date": "20210930",
      "report_date": "20161026",
      "code_info": "All lots."
    }
  ]
}